Who backs Interius BioTherapeutics?
20 investors| Investor | Type |
|---|---|
| Osage University Partners | Venture capital |
| Cormorant Asset Management | Venture capital |
| Pfizer Ventures | Other |
| Logos Capital | Hedge fund |
| Knollwood Investment Advisory | Other |
| Bain Capital Life Sciences | Venture capital |
| BrightEdge | Venture capital |
| ACS BrightEdge | — |
| Agent Capital | — |
| DC Investment Partners | — |
| + 10 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Interius BioTherapeutics investors
20 investors are on record for Interius BioTherapeutics, including Osage University Partners, Cormorant Asset Management, Pfizer Ventures and Logos Capital. By type, the record holds 4 venture capital firms and 1 hedge fund. The later-stage round in May 2024 drew 12 investors.
Free account
More of Interius BioTherapeutics with a free account
- ·The complete investor list: 20 names
- ·Watch Interius BioTherapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 20 firms already write checks for companies like Interius BioTherapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View